Aarkstore.com 10% Discount || Antifungals Market to 2017 – Generic Erosion of Major ||

Aarkstore.com announces- 10% Discount on-Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth

ListFree.org (Press Release) - Tuesday, August 7th, 2012 -

Aarkstore.com announces, The Latest market research report is available in its vast collection:

Antifungals Market to 2017 – Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth

http://www.aarkstore.com/reports/Antifungals-Market-to-2017-Generic-Erosion-of-Major-Polyenes-Azoles-Allylamines-and-Echinocandins-to-Slow-Value-Growth-107118.html

In-depth analysis of the report is based on propriety databases, primary and secondary research and in-house analysis by the GBI Research team of experts.

GBI Research analysis shows that the global antifungals market was estimated at $9.4 billion in 2010, with a Compound Annual Growth Rate (CAGR) of 2.9% during 2002 and 2010. The antifungals market is dominated by generics. GBI Research forecasts that the market will grow at a CAGR of 1.9% during 2010-2017 to $10.8 billion. The patent expiry of a number of major drugs has paved way for the entry of generics.

GBI Research analysis shows that the R&D pipeline for the antifungals market is not strong as it has become a generic market. Currently, only 38 molecules are in R&D, which indicates that antifungals R&D activity will not be very active for at least the next seven to eight years.

Scope

•Data and analysis on the antifungals market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
•Annualized market data for the antifungals market from 2002-2010 with forecasts to 2017.
•Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population.

Table of contents:

1.1 List of Tables
1.2 List of Figures
2. Global Antifungals Market to 2017 – Introduction
2.1 Overview
2.2 GBI Research Report Guidance
3. Global Antifungals Market to 2017 – Market Characterization
3.1 Introduction
3.2 Different Classes of Antifungals
3.3 Forecast for Global Antifungals Market
3.3.1 Revenues
3.3.2 Branded and Generic Market Share
3.3.3 Annual Cost of Treatment (ACT)
3.3.4 Treatment Usage Patterns
3.4 Drivers for the Antifungals Market
3.4.1 Large Patient Population
3.4.2 Increase in Diagnosis Rate
3.5 Barriers for the Antifungals Market
3.5.1 Prominence of Generics in the Market
3.5.2 High Unmet Need in Case of Serious Invasive Fungal Infections
4. Global Antifungals Market – Geographical Landscape
4.1 Revenue Analysis by Geography
4.2 The US
4.2.1 Revenue
4.2.2 Annual Cost of Treatment
4.2.3 Treatment Usage Pattern
4.3 Top Five Countries of Europe
4.3.1 Revenue
4.3.2 Annual Cost of Treatment
4.3.3 Treatment Usage Pattern
4.4 Japan
4.4.1 Revenue
4.4.2 Annual Cost of Treatment

List of Figures

List of Tables are also include.

For more DISCOUNT related Reports Plz follow The link:

Cardiac Rhythm Management Devices Market to 2017 – Technological Innovations, Regulatory Approvals and Increasing Disease Prevalence Present Growth Opportunities

Cardiac Assist Device Market to 2017 – Increasing Uptake of Ventricular Assist Devices and Total Artificial Heart to Drive Growth

Generic Growth Strategies – Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues

Rx-to-OTC Switching Strategies – New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge

Antifungals Market to 2017 – Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1

Biobetters in Key Markets – Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings

Generic Growth Strategies – Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues

Rx-to-OTC Switching Strategies – New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge

Antifungals Market to 2017 – Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth

You can also request for sample page of above mention reports on sample@aarkstore.com

For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com

ListFree.org: Embedded data.

Bookmark and Share Subscribe

pdf

 

Contact us at :
Issued By:+918149852585
Email:sunaark08@gmail.com
Town:houston
Country:united states
Phone:+918149852585
WebSite:http://www.aarkstore.com/
Categories:Uncategorized
Tags:

You can leave a response, or trackback from your own site.


Related Posts
    No matches

Leave a Reply

You must be logged in to post a comment.